FDA Inspection
Catalent Greenville IncCatalent Greenville Inc – FDA Inspection, Oct 24, 2025
Record Details
This FDA Inspection record concerns Catalent Greenville Inc, with an inspection on October 24, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · e70481ed-ec74-44fe-a523-966e8da08563
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1267356
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.166(a)Written program not followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalent Greenville Inc
12| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Catalent Greenville Inc
- FDA Inspection 1231042 - 2024-01-31
- FDA Inspection 1097051 - 2019-07-12
- FDA Inspection 1065149 - 2018-08-24
- FDA Inspection 1019260 - 2017-04-13
- FDA Inspection 983236 - 2016-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.